Indian Journal of Endocrinology and Metabolism

ESICON 2012 KOLKATA MINI-REVIEW
Year
: 2013  |  Volume : 17  |  Issue : 2  |  Page : 245--248

New options for the medical treatment of Cushing«SQ»s syndrome


Peter J Trainer 
 Department of Endocrinology, The Christie NHS Foundation Trust, Manchester, United Kingdom

Correspondence Address:
Peter J Trainer
Department of Endocrinology, The Christie NHS Foundation Trust, Manchester
United Kingdom

A number of drugs have been advocated for the medical management of Cushing«SQ»s syndrome but few have gained widespread acceptance. The most reliably effective agents are metyrapone and ketoconazole as monotherapy, or in combination. Cabergoline may be of value in a minority of patients but pasireotide is a more reliable and effective agent that lowers cortisol secretion in the great majority of patients, although only normalises UFC in a minority. The potential for combination of an agent that blocks adrenal steroidogenesis with inhibition of ACTH secretion by pasireotide needs to be explored.


How to cite this article:
Trainer PJ. New options for the medical treatment of Cushing's syndrome.Indian J Endocr Metab 2013;17:245-248


How to cite this URL:
Trainer PJ. New options for the medical treatment of Cushing's syndrome. Indian J Endocr Metab [serial online] 2013 [cited 2021 Sep 17 ];17:245-248
Available from: https://www.ijem.in/article.asp?issn=2230-8210;year=2013;volume=17;issue=2;spage=245;epage=248;aulast=Trainer;type=0